Evaluating non-invasive methods for diagnosing chronic liver disease
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease. a Retrospective and Prospective 20-year Follow-up.
This study is trying to see if non-invasive tests can help predict how well people with chronic liver disease will do over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Association HGE CHU Bordeaux Sud Academic / other |
| Locations | 1 site (Pessac) |
| Trial ID | NCT02060565 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the long-term prognosis value of non-invasive diagnostic methods for chronic liver disease over a 20-year period. It will follow patients diagnosed with chronic liver conditions, including hepatitis C, hepatitis B, alcohol-related liver disease, and non-alcoholic liver disease. The study will analyze how these methods can predict survival rates and complications associated with cirrhosis. Both retrospective and prospective data will be collected to provide a comprehensive understanding of the disease progression.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with chronic hepatitis C, chronic hepatitis B, alcohol liver disease, or non-alcoholic liver disease.
Not a fit: Patients with ascites will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could improve the accuracy of diagnosing chronic liver disease and enhance patient management strategies.
How similar studies have performed: Other studies have shown promise in using non-invasive methods for diagnosing liver diseases, indicating that this approach is gaining traction in the medical field.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * chronic hepatitis C * chronic hepatitis B * alcohol liver disease * non alcoholic liver disease Exclusion Criteria: * ascitis
Where this trial is running
Pessac
- Centre d'Investigation de la Fibrose hépatique Service Hépato-Gastroentérologie Hopital Haut-Lévèque — Pessac, France (Recruiting)
Study contacts
- Study coordinator: Victor de Lédinghen, MD, PhD
- Email: victor.deledinghen@chu-bordeaux.fr
- Phone: 0033557656439
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.